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High-risk human papillomaviruses (e. g., HPV16, HPV18) are closely associated with the development of
head and neck cancers including oral/oropharyngeal squamous cell carcinoma (OSCC). We previously
demonstrated immortalization of normal human oral keratinocytes by introducing high-risk HPV whole
genome, suggesting that HPV infection plays an important role in the early stage of oral carcinogenesis.
Although HPV infection may occur in different stages of cancer development, roles of HPV in exacer-
bating malignant phenotypes in already-transformed cells in the context of cancer stemness are not
clearly deﬁned. In this study, we investigated the role of HPV16 in promoting the virulence of HPV-
negative OSCC. Introducing HPV16 whole genome in HPV-negative OSCC increased malignant growth
and self-renewal capacity, a key characteristic of cancer stem cells (CSCs). HPV16 also enhanced other
CSC properties, including aldehyde dehydrogenase 1 (ALDH1) activity, migration/invasion, and CSC-
related factor expression. Mechanistically, we found that HPV16 inhibited the expression of miR-181a
and miR-181d (miR-181a/d) at the transcriptional level. Ectopic expression of miR-181a/d decreased
anchorage independent growth and CSC phenotype of HPV16-transfected OSCC. Furthermore, silencing
of miR-181a/d target genes, i. e., K-ras and ALDH1, abrogated the effects of HPV16 in HPV16-transfected
OSCC, supporting the functional importance of HPV16/miR-181a/d axis in HPV-mediated oral carcino-
genesis. Our study suggests that high-risk HPV infection further promotes malignancy in HPV-negative
OSCC by enhancing cancer stemness viamiR-181a/d regulation. Consequently, miR-181a/d may represent
a novel therapeutic agent for the treatment of HPV-positive OSCC.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
OSCC is the sixth most common cancer and an important public
health concern worldwide [1]. Risk factors for OSCC development
in the elderly are typically associated with a life-long history of
cigarette smoking and heavy alcohol consumption [2,3]. Recent
studieshaveshown that there is anincreasing incidence of oral
cancer among young adults [4,5] and that a signiﬁcant percentage
of OSCC cases in young adults were non-habitués [6]. Indeed, 34%B.V. This is an open access article u
ancer stem cells; OSCC, Oral/
icroRNA; IL4, ALDH1, Alde-
nter for the Health Sciences,
, CA 90095, United States.
in).of the cases in young adults did not show any tobacco/alcohol
related habits [7], but rather, changes in sexual behaviors was one
of the contributing factors for this increasing incidence of oral
cancer in young adults.
HPV is a DNA virus that is typically transmitted through sexual
contacts. Many studies revealed that high-risk HPV (e. g., HPV16,
HPV18) is an additional independent risk factor for oral cancer
[8,9]. HPV infection is closely linked to benign and malignant oral
lesions [10] and up to 30–40% of oral cancer biopsies contain the
viral DNA [11]. Despite the saturated understanding of HPV-
inducing immortalization mechanisms in normal human epithelial
cells, not much is known about the possible role and the under-
lying mechanisms of HPV in promoting the virulence of already
transformed cells, such as HPV-negative OSCC.
Recent studies have unveiled and validated the pathophysiologic
role of CSCs (alternatively cancer initiating cells) in long-term sus-
tenance of cancers [12]. CSCs are small subpopulations of tumor cellsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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embryonic and normal adult stem cells. CSCs have been isolated from
various primary tumors and established cancer cell lines, including
OSCC [13,14]. They are also potentially responsible for drug resis-
tance, metastasis, and recurrence of cancers. Therefore, CSCs drive
the perpetuity of the disease while producing cellular heterogeneity
of cancer tissues, making them strategically plausible targets for
cancer therapies. The phenotypes of CSC have been reported to be
maintained by several endogenous signaling pathways, such as
Notch, Hedgehog, and Wnt [15,16], which are frequently activated in
human cancers [16–18]. In addition, increasing numbers of publica-
tions reported that CSCs can be epigenetically regulated by micro-
RNAs (miRNAs) [19,20].
miRNAs are one of major epigeneticregulators of eukaryotic gene
expression [21]. miRNAs are 21–25 nucleotide non-coding RNAs that
bind to the target mRNAs at their 3′ untranslated region (UTR) and
suppress the gene expression. They are estimated to regulate at least
one-third of all human genes and play key roles in many cellular
processes, including cancer development and stemness maintenance
[22,23]. Many studies identiﬁed various miRNAs affecting CSC phe-
notype [20,24]. For instance, miR-34a suppresses CSCs by repressing
CD44 [25], and miR-200 inhibits CSC self-renewal and properties by
suppressing diverse target genes [26,27]. Interestingly, various studies
showed that miRNA expression pattern is affected by HPV status in
human SCC [28,29]. These observations suggest the potential role of
HPV/miRNA axis in oral cancer progression in the context of epigenetic
regulation of CSCs.
In the present study, we provide evidence that high-risk HPV16
enhances malignant growth and CSC phenotype of HPV-negativeFig. 1. HPV16 increases tumor growth of HPV-negative OSCC both in vitro and in vivo. Fou
with pMHPV-16d containing a head-to-tail dimer of HPV-16 whole genome or with pd
culture medium containing 200 mg/ml of G418, then subcultured and used for experimen
determined by soft agar assay. Data are means7SD of triplicate experiments. nPo0.00
HPV16-transfected OSCC cell lines (SCC105/HPV16 and UM6/HPV16) and their empty
magniﬁcation of 40 . (C) Organotypic raft cultures were established with HPV16-transf
UM10b). Brackets indicate epithelial thickness, while arrows indicate inﬁltrating island
igenicity of HPV-negative OSCC was determined by xenograft tumor assay. UM6 and UM6
5, and tumors were surgically removed from all animals, weighted, and photographed.OSCC cells by suppressing tumor suppressive miRNAs, miR-181a
and miR-181d. Our study suggests that HPV infection in pre-
cancerous and cancerous lesions may potentiate malignant phe-
notypes by affecting CSC-enriched populations through miRNA-
mediated epigenetic regulation and it can ultimately dictate the
cancer progression.2. Materials and methods
2.1. Cells and cell culture
Four HPV-negative OSCC cell lines (SCC66, SCC105, UM6,
UM10b [30]) were cultured in DMEM/Ham's F12 (Invitrogen)
supplemented with 10% FBS (Gemini Bioproducts) and 0.4 mg/ml
hydrocortisone (Sigma-Aldrich).2.2. Transfection with HPV16 whole genome
Approximately 70% of conﬂuent OSCC cells grown in 60 mm
Petri dishes were transfected with pMHPV-16d, a head-to-tail
dimer of HPV-16 DNA inserted into the plasmid pdMMTneo or
pdMMTneo by using the Lipofectin reagent [31]. To select cells
transfected with the pMHPV-16d or pdMMTneo plasmid, the cells
were incubated in a culture medium containing 200 mg/ml of G418
(GIBCO, Grand Island, NY) and G418-resistant cells were isolated,
subcultured and used for experiments.r HPV-negative OSCC cell lines (SCC66, SCC105, UM6, and UM10b) were transfected
MMTneo, an empty vector as the control. Stable transfected cells were selected in
ts. (A) Effect of HPV16 on anchorage independent growth of HPV-negative OSCC was
1 by two-tailed Student's t test. (B) Representative images of colonies formed by
vector-transfected controls (SCC105 and UM6). The photographs were taken at a
ected OSCC cell lines (UM6/HPV16 and UM10b/HPV16) and their controls (UM6 and
s of cells through the basement membrane. (D) Effect of HPV16 on in vivo tumor-
/HPV16 were injected subcutaneously into ﬁve nude mice. Mice were killed at week
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To determine colony-forming efﬁciency in semi-solid medium,
1104 cells were plated in culture medium containing 0.3%
agarose over a base layer of serum-free medium containing 0.5%
agarose. Two weeks after incubation, the colonies were counted.
The experiment was performed in triplicates with 60-mm dishes.2.4. Organotypic raft cultures
One million cells were seeded on the submucosal equivalents
consisting of type I collagen and normal human oral ﬁbroblasts.
The cells were grown to conﬂuence, submerged in the culture
medium, and then exposed to the liquid–air interface by lowering
the medium level. The cultures were maintained in this “rafting”
fashion for 14 days and were harvested by ﬁxing in 10% buffered
formalin. Subsequently, hematoxylin–eosin (H&E) staining was
performed on thick (6 μm) sagittal sections of each reconstructs to
reveal the histological features. Sample processing, parafﬁn-
embedding, sectioning, and H&E staining were performed at
UCLA’s Translational Pathology Core Laboratory (TPCL).2.5. In vivo xenograft tumor assay
Four million cells were subcutaneously injected into the ﬂank of
immunocompromised mice (strain nu/nu, Charles River Laboratories).
The animal study was performed according to the protocol approved
by UCLA Animal Research Committee. The kinetics of tumor growth
was determined by measuring the volume in three perpendicular
axes of the nodules using micro-scaled calipers.Fig. 2. HPV16 promotes self-renewal capacity of HPV-negative OSCC. (A) Effect of HPV1
formation assay. Data are means7SD of triplicate experiments. nPo0.001, nnPo0.01,
spheres formed by HPV16-transfected OSCC cell lines (SCC66/HPV16 and SCC105/HPV16)
at a magniﬁcation of 40 . (C) Effect of HPV16 on stemness transcription factor express
were normalized with the level of GAPDH. Their levels in HPV16-transfected OSCC cell2.6. Tumor sphere formation assay
Three thousand cells were grown in 3 ml of serum-free DMEM/
F12 media supplemented with 1:50 B27 (Invitrogen), 20 ng/ mL
EGF, 20 ng/ mL, 10 μg/ mL insulin, penicillin, streptomycin, and
amphotericin B in Ultra-Low Attachment 6-well Plates (Corning)
for 6–10 days. The assay was performed in triplicate and the
number of tumor spheres that formed were observed and counted
under a microscope.
2.7. Quantitative real-time PCR (qPCR)
cDNAwas synthesized from 5 μg of total RNA using SuperScript
ﬁrst-strand synthesis system (Invitrogen). We used 1 μl cDNA for
qPCR ampliﬁcation with SYBR Green I Master mix (Roche) and
LightCycler 480 II (Roche). The primer sequences were obtained
from the Universal Probe Library (Roche), which are available upon
request. Second derivative Cq value determination method was
used to compare fold-differences according to the manufacturer’s
instructions.
2.8. ALDH1 assay
We used Aldehyde Dehydrogenase-Based Cell Detction Kit
(STEMCELL) to determine ALDH1 enzymatic activity. A total of
1106 cells were re-suspended in 1 mL of ALDEFLUOR Assay
Buffer. Fluorescent nontoxic ALDEFLUOR Reagent BODIPYTM
(1.25 ml) was added as a substrate to measure ALDH1 enzymatic
activity in intact cells. Immediately after adding the substrate
reagent, 0.5 ml of the cell suspension was transferred into the
control tube which contained a speciﬁc inhibitor for ALDH1, die-
thylaminobenzaldehyde (DEAB) for calculating background6 on self-renewal capacity of HPV-negative OSCC was determined by tumor sphere
and nnnPo0.05 by two-tailed Student's t test. (B) Representative images of tumor
and their corresponding controls (SCC66 and SCC105). The photographs were taken
ion in HPV-negative OSCC was determined by real-time qPCR. Levels of the factors
lines were plotted as fold induction against those in their corresponding controls.
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and ﬂuorescence data acquisition was made by using a BD FACScan
ﬂow cytometer (BD Biosciences).2.9. Migration and invasion assay
Cell migration was measured using transwell chambers with
polycarbonate membranes (Corning) as described in our previous
publication [32]. Cell invasion was measured using Matrigel
Basement Membrane Matrix (BD Biosciences) according to the
method as described in manufacture protocol.2.10. Overexpression of miR-181
10μM of pre-miR-181a and 181d (Ambion) was used indivi-
dually or combined together with Lipofectamin 2000 (Invitrogen).
Initially 8x105 cells were seeded on 60 mm dish for 6 h prior to
transfection. Transfecting solution was prepared by mixing the
10 μl of Lipofectamin 2000 with 20 μl of siRNA and 470 μl of
culture medium. After 5 min of incubation at room temperature,
the transfecting solution was added to the cell for overnightFig. 3. HPV16 promotes CSC properties of HPV-negative OSCC. (A) Effect of HPV16 on AL
labeled with Aldeﬂuor combined with or without the ALDH1 inhibitor DEAB and analyz
DEAB control (þDEAB) and shows the brightly ﬂuorescent ALDH1 population versus th
number shown in each panel reﬂects the percentage of ALDH1þ cells in each cell type. (B
in HPV16-transfected OSCC cell lines were plotted as fold induction against those in their
on migration ability in HPV-negative OSCC was determined by transwell migration assay
mean7SD for 3 randomly selected ﬁelds. nPo0.05, nnPo0.01, and nnnPo0.001 by two-t
above the graph. (D) Effect of HPV16 on invasion ability of HPV-negative OSCC was dete
invaded cells per ﬁeld with the data as mean7SD for 3 randomly selected ﬁelds. nnPo0.
invasion assay are shown above the graph.incubation at 37 °C. For the negative control, we used 5nM of
negative control #1 pre-miR (Ambion).
2.11. qPCR analysis of miR-181
Total RNA was extracted from cell cultures using Trizol Reagent
(Invitrogen). A cDNA pool of miRNAs was synthesized by Quanti-
Mir cDNA Kit (System Biosciences) according to the manufacturer's
protocol. Next, miRNAs were ampliﬁed using the SYBR Green I
Master PCR Mix (Roche) with the LightCycler 480 II real time PCR
system (Roche). For miR-181a ampliﬁcation, one primer is mature
miR-181a speciﬁc (5′-aacattcaacgctgtcggtgagt-3′) and the other is
the company-provided universal primer. U6 small nuclear RNA
(snRNA) level was used as an internal control for the starting
amount of cDNA.
2.12. Luciferase report assays
The pGL3-615 plasmid containing a minimal regulatory region
of miR-181a’s promoter (615 to þ1) was used in this study [33].
Transfection and luciferase assay were carried out as described in
previous publications. For normalization of transfection efﬁciency,DH1 activity in HPV-negative OSCC was determined by Aldeﬂuor assay. Cells were
ed by ﬂow cytometry. The gate for ALDH1 þ cells is determined in relation to the
e side scatter, a population that is absent/decreased in the presence of DEAB. The
) Effect of HPV16 on ALDH1 mRNAwas determined by real-time qPCR. ALDH1 levels
corresponding controls. nPo0.001 by two-tailed Student’s t test. (C) Effect of HPV16
. Migration ability was described as number of migrated cells per ﬁeld with data as
ailed Student's t test. Representative images of transwell migration assay are shown
rmined by Matrigel invasion assay. Invasion ability was described as the number of
01 and nnnPo0.001 by two-tailed Student’s t test. Representative images of Matrigel
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taining the renilla luciferase gene under SV40 promoter.
2.13. Knockdown of K-ras and ALDH1 using siRNA
K-ras and ALDH1 were knocked down with duplex siRNA tar-
geting K-ras (Santa Cruz Biotech) and ALDH1 (Santa Cruz Biotech),
respectively. The cells were also transfected with scrambled siRNA
(Santa Cruz Biotech) as the control. Transfection was carried out
using Lipofectamine RNAiMAX (Invitrogen). OSCC cells (2105)
were plated in 60-mm dishes and transfected with 15 μg siRNA.
Finally, the cultures were harvested after two days post-transfec-
tion for expression and functional analyses.
2.14. Western blotting
Western blotting was performed as previously described [32].
We used the following primary antibodies for this study: K-ras (C-
19; Santa Cruz Biotech) and GAPDH (Santa Cruz Biotech).3. Results
3.1. HPV16 enhances tumor growth of HPV-negative OSCC cells both
in vitro and in vivo
To investigate whether high-risk HPV can further promote the
malignant phenotype of HPV-negative OSCC, we ﬁrst transfected
four HPV-negative OSCC cell lines (SCC66, SCC105, UM6, UM10b)
with HPV16 whole genome. All of the HPV16-transfected OSCC cell
lines expressed HPV16 E6 and E7 (data not shown). Then, we
examined the effect of HPV16 on the anchorage independent
growth ability of HPV-negative OSCC by performing soft agarFig. 4. HPV16 downregulates the expression of miR-181a and miR-181d by inhibiting mi
181b, miR-181c, and miR-181d) in the HPV16-transfected cell lines and their controls we
miR-181a promoter activity was determined by luciferase promoter assay. Cells were tr
miR-181a promoter region (-615 to þ1). The cells were also cotransfected with pRL-SV4
Student’s t test.assays. All HPV16-transfected OSCC cell lines showed robust
induction of anchorage independent growth compared to their
empty vector-transfected controls (Fig. 1A and B). We also
employed an in vivo-like 3-demensional organotypic cell culture
system where we could reconstitute squamous epithelium in vitro
[32,33]. Organotypic cultures of the HPV16-transfected cells
showed malignant histomorphology with invasive characteristics
into the subepithelial layer and formed thicker squamous epithe-
lium than those of their control cells (Fig. 1C). To extend these
observations, we investigated the effect of HPV16 on in vivo
tumorigenicity of HPV-negative OSCC cells by performing xeno-
graft tumor assay in nude mice. The HPV16-transfected cells
(UM6/HPV16) exhibited robust increase in xenograft tumor
growth and tumor forming ability compared to their control cells
(UM6) (Fig. 1D). These ﬁndings collectively indicate that high-risk
HPV16 further enhances tumorigenicity of HPV-negative OSCC.
3.2. HPV16 promotes self-renewal capacity and CSC properties of
HPV-negative OSCC cells
A key feature of CSCs is self-renewal capacity, which appears to
be a driving force for the initiation and maintenance of tumor-
igenicity [12]. CSCs have been previously isolated from HPV-
positive SCC [34]. To determine the effect of high-risk HPV on self-
renewal capacity of HPV-negative OSCC, we employed tumor
sphere formation assay in which CSCs can be enriched in non-
adherent tumor spheres [32]. Abundance and the growth kinetics
of tumor spheres are indicative of CSC content and self-renewal
capacity in a given culture of heterogeneous cancer cells. All
HPV16-transfected OSCC cell lines displayed robust increase in
tumor sphere-forming ability compared to their empty vector-
transfected controls (Fig. 2A and B). The effect of HPV16 on self-
renewal was further conﬁrmed by evaluating the expression ofR-181 promoter activity. (A) The levels of miR-181 family members (miR-181a, miR-
re measured by real-time qPCR and normalized to U6 snRNA. (B) Effect of HPV16 on
ansfected with pGL3-Basic (promoter-less) or pGL3 vectors containing the minimal
0 to monitor the transfection efﬁciency. nnP o 0.01 and nnnP o 0.001 by two-tailed
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OSCC cell lines consistently exhibited higher gene expression
levels of Oct4, Nanog, KLF4, c-Myc, and Bmi1 than the empty
vector controls. Our ﬁndings indicate that HPV16 promotes self-
renewal capacity of HPV-negative OSCC.
Next, we further investigated the effect of HPV16 on CSC
properties in HPV-negative OSCC. Aldehyde dehydrogenase 1
(ALDH1) activity is an important CSC marker and is enriched in
CSCs of head and neck cancer [34]. The ﬂow cytometric analysis
revealed a signiﬁcant increase in ALDH1þ (or ALDH1 high) cell
population in the HPV16-transfected cells compared to their cor-
responding controls (48.13% versus 11.62% and 21.9% versus 7.72%;
Fig. 3A). We also observed robust induction of ALDH1 mRNA in the
HPV16-transfected cells (Fig. 3B). Because another well-known
property of CSCs is their metastatic potential [12], we examined
the effect of HPV16 on migration and invasion of HPV-negative
OSCC in vitro. As demonstrated by a transwell migration assay
(Fig. 3C), all HPV16-transfected OSCC cell lines migrated sig-
niﬁcantly faster than their corresponding controls. We also found a
signiﬁcant increase in invasion in all HPV16-transfected OSCC cell
lines as shown by Matrigel invasion assay (Fig. 3D). Overall, our
data indicate that high-risk HPV16 enriches CSC population and
properties in HPV-negative OSCC.Fig. 5. Ectopic expression of miR-181a/d suppresses anchorage independent growth and
overexpression of miR-181a and miR-181d in UM6/HPV16 transfected with pre-miR-mi
gonucleotides (SCR) were used as a control transfection. Levels of miRNAs were meas
independent growth assay. nSigniﬁcantly different (Po0.01, Student's t test) from the
transfected with miR-181a/d and SCR are shown on the right side. (C) Tumor sphere for
the SCR-transfected cells. (D) Transwell migration assay. nSigniﬁcantly different (Po0.0
migration assay from UM6/HPV16 transfected with miR-181a/d and SCR are shown on th
and CSC-related genes in UM6/HPV16 were examined by real-time qPCR.3.3. HPV16 increases anchorage independent growth and CSC phe-
notype of HPV-negative OSCC cells by suppressing miR-181a and miR-
181d
Recent studies clearly demonstrated that HPV status affect the
miRNA expression pattern in human SCC [28,29]. To understand the
role of miRNAs that are speciﬁc for high-risk HPV16, we compared
global miRNA expression proﬁles of HPV16-transfected OSCC cells
(SCC105/HPV16 and UM10b/HPV16) with their empty vector con-
trols (SCC105 and UM10b) using miRCURY LNATM miRNA Array
(Exiqon). We identiﬁed 34 miRNAs that were altered greater than
2-fold, po0.05 by HPV16 in both cell lines (data not shown).
Among them, 15 miRNAs were downregulated and 19 miRNAs were
upregulated by HPV16. We then compared the expression of these
34 miRNAs in the four HPV16-transfected cell lines versus their
corresponding controls (data not shown). Two miR-181 family
members, miR-181a and miR-181d, were consistently down-
regulated in all of the HPV16-transfected cell lines (Fig. 4A). How-
ever other miR-181 members, miR-181b and miR-181c, were not
consistently altered by HPV16 (Fig. 4A). To further understand the
mechanism of miR-181 downregulation by HPV16, we utilized the
miR-181a promoter construct, whose luciferase activity is driven by
the 615-bp minimal promoter sequence of miR-181a [33]. When
transfected with the miR-181a promoter constructs, the HPV16-CSC phenotype in HPV16-transfected OSCC. (A) Real-time qPCR analysis of ectopic
R-181a (miR-181a), pre-miR-181d (miR-181d), or both (miR-181a/d). Scramble oli-
ured 3 day posttransfection and normalized to that of U6 snRNA. (B) Anchorage
SCR-transfected cells. Representative images of colonies formed by UM6/HPV16
mation assay. Signiﬁcantly different (nPo0.05 and nnPo0.01, Student's t test) from
1, Student's t test) from other transfected cells. Representative images of transwell
e right side. (E) Effects of miR-181a and miR-181d on stemness transcription factors
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to their corresponding control cells, indicating that miR-181a is
transcriptionally repressed by HPV16 (Fig. 4B).
Having determined that miR-181a and miR-181d are tran-
scriptional targets of HPV16, we next sought to demonstrate the
HPV16’s enhancing capacity of tumor growth and CSC phenotype
by repressing miR-181. We overexpressed miR-181a and miR-181d
in the HPV16-transfected cells (UM6/HPV16) by transfecting with
pre-miR-181a, pre-miR-181d or both (Fig. 5A). These transfected
pre-miRNAs do not contain their natural promoters; therefore,
these miRNAs were expected to reconstitute their expressions in
the presence of HPV. Consistent with our previous ﬁnding [33],
overexpression of miR-181a and miR-181d suppressed anchorage
independent growth ability of the HPV16-transfected cells
(Fig. 5B). miR-181a and miR-181d also decreased the tumor
sphere-forming ability of UM6/HPV16 (Fig. 5C). Interestingly, the
combination of miR-181a and miR-181d (miR-181a/d) showed the
most potent inhibitory effect on anchorage independent growth
and self-renewal capacity of the cells. We also found the strongest
inhibitory effect of miR-181a/d on the migratory ability of UM6/
HPV16 (Fig. 5D). The inhibitory effect of miR-181a/d on CSC phe-
notype was further validated by qPCR analysis of stemness tran-
scription factors and CSC-related genes (Fig. 5E). We observed that
miR181a/d suppressed stemness transcription factors (i. e., Oct4,
Nanog, KLF4, Lin28) and CSC-related genes (i.e., ALDH1, Hes1,
Hey1, Gli1, FGF4) in UM6/HPV16. However, miR-18a/d did not alter
viral gene expression such as E6 and E7 (data not shown). Our
ﬁndings indicate that HPV16 enhances tumor growth and CSC
phenotype of HPV-negative OSCC cells by transcriptionally sup-
pressing miR-181a/d.Fig. 6. Silencing of K-ras, a miR-181a/d target, inhibits anchorage independent growth
K-ras in HPV16-tranfected OSCC cell lines was determined by Western blot analysis. GA
181a/d decreased K-ras in UM6/HPV16 as determined by Western blot analysis. (C) End
siRNA). The cells transfected with control siRNA (CTLi) were included for comparison. (D
determined by soft agar assay. nPo0.05 by two-tailed Student’s t test. (E) Effect of K-
migration assay. nPo0.05 by two-tailed Student’s t test. Representative images of trans
shown on the right side. (F) Effect of K-ras knockdown on self-renewal capacity of UM63.4. Silencing of miR-181a/d target genes abrogates the effect of
HPV16 in HPV16-transfected OSCC cells
Previously, we reported that miR-181a elicits tumor suppres-
sive activity against OSCC by downregulating K-ras [33]. miR-181a
inhibits K-ras translation by regulating the 3′-UTR of K-ras gene
[33]. miR-181d also acts as tumor suppressor by targeting K-ras
[35]. To investigate whether HPV16/miR-181a/d axis enhances
tumor growth and CSC phenotype by regulating target gene(s) of
miR-181a/d, we ﬁrst examined the role of K-ras. We conﬁrmed
that K-ras was increased in the HPV16-transfected OSCC cell lines
(Fig. 6A) and then tested to see if increased K-ras is attributable to
the downregulation of miR-181a and miR-181d in the HPV16-
transfected cells. Overexpression of miR-181a and miR-181d
notably decreased the level of K-ras expression in UM6/HPV16,
indicating that K-ras was indeed increased by HPV16 via the
downregulation of miR-181a and miR-181d (Fig. 6B). Furthermore,
we examined if knockdown of K-ras would abrogate the effects of
HPV16 on UM6/HPV16. We successfully knocked down K-ras in
UM6/HPV16 using siRNA (Fig. 6C). K-ras siRNA signiﬁcantly
inhibited anchorage independent growth and migration ability of
UM6/HPV16 (Fig. 6D and E). However, knockdown of K-ras mar-
ginally suppressed tumor sphere-forming ability of the cells
(Fig. 6F), suggesting that multiple targets of miR-181a/d may be
responsible for the HPV16-induced CSC phenotype in OSCC cells.
To test this possibility, we sought to identify other target(s) of
miR-181a/d involved in the HPV16-induced CSC phenotype.
Increased ALDH1 by HPV16 (Fig. 3A and B) and decreased ALDH1
by miR-181a/d in the HPV16-transfected cells (Fig. 5E) suggest a
possible role of ALDH1 in the CSC regulation by the HPV16/miR-and migration ability in HPV16-transfected OSCC cells. (A) Decreased expression of
PDH was used as controls. (B) Ectopic expression of miR-181a, miR-181d, and miR-
ogenous K-ras in UM6/HPV16 was knocked down using siRNA against K-ras (K-ras
) Effect of K-ras knockdown on anchorage independent growth in UM6/HPV16 was
ras knockdown on migration ability of UM6/HPV16 was determined by transwell
well migration assay from UM6/HPV16 transfected with CTLi and K-ras siRNA are
/HPV16 was determined by tumor sphere formation assay.
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both ALDH1 mRNA (Fig. 7A) and ALDH1þ cell population (Fig. 7B)
in UM6/HPV16 cells, indicating that ALDH1 is a downstream target
of HPV16/miR181a/d axis. To investigate the functional role of
ALDH1 in the CSC regulation by the HPV16/miR-181 axis, we
knocked down ALDH1 in UM6/HPV16 cells using siRNA (Fig. 7C
and D). ALDH1 siRNA signiﬁcantly suppressed self-renewal capa-
city, as demonstrated by tumor sphere formation assay (Fig. 7E).
Knockdown of ALDH1 also inhibited anchorage independent
growth ability of UM6/HPV16 (Fig. 7F). These ﬁndings signify the
importance of ALDH1 in the CSC phenotype increased by the
HPV16/miR-181 axis. Taken together, our ﬁndings indicate the
functional role of miR-181a/d target genes under the HPV16/miR-
181a/d axis in further malignant progression of HPV-negative
OSCC by high-risk HPV16.4. Discussion
Here, we demonstrated for the ﬁrst time that high-risk HPV16
enhances tumor growth and cancer stemness of HPV-negative
OSCC via miR-181a/d regulation. HPV16 represses miR-181 byFig. 7. ALDH1 is a downstream target of miR-181a/d, and its knockdown inhibits self-ren
of miR-181a/d on ALDH1 mRNA in UM6/HPV16 was determined by miR-18a/d transfecti
HPV16 was determined by Aldeﬂuor assay. The number shown in each panel reﬂects t
HPV16 was knocked down using siRNA against ALDH1 (ALDH1 siRNA). Decreased ALD
determined by Aldeﬂuor assay. Relative ALDH1 activity was obtained from ALDH1þ c
(E) Effect of ALDH1 knockdown on self-renewal capacity of UM6/HPV16 was determined
of tumor spheres formed by UM6/HPV16 transfected with CTLi and ALDH1 siRNA were s
growth of UM6/HPV16 was determined by soft agar assay. nPo0.05, Student's t test. (G)
miR-181a/d targets and promotion of malignant growth and CSC phenotype in HPV-neinhibiting its promoter activity. We also provide the evidence that
miR-181a/d regulate tumor growth and CSC phenotype by reg-
ulating their multiple target genes in HPV16-positive OSCC cells,
indicating the importance of miR-181/miR-181 targets axis in
HPV-mediated oral carcinogenesis (Fig. 7G). Thus, our study
highlights the important role of high-risk HPV in malignant pro-
gression of HPV-negative OSCC by enriching cancer stemness via
epigenetic regulators, miRNAs.
Previously, we have studied the role of HPV in oral carcino-
genesis, particularly focusing on the mechanisms of the trans-
forming capacity of high-risk HPVs (i.e., HPV16 and HPV18) in
normal human oral keratinocytes (NHOKs). We reported success-
ful immortalization of NHOK by transfection with high-risk HPV
whole genome, but failed to yield neoplastic conversion of the
normal cells [31,36]. This suggested that HPV infection plays an
important role in the early stage of oral carcinogenesis. However,
the possible role of HPV in malignant progression of already
transformed cells, i.e., HPV-negative OSCC has not been well
documented. Our study clearly demonstrated that high-risk HPV16
further promotes malignant growth of HPV-negative OSCC cells
in vivo and in vitro. This ﬁnding is consistent with the results of a
previous study reporting that HPV16 induced signiﬁcant increasesewal and anchorage independent growth of HPV16-transfected OSCC cells. (A) Effect
on followed by real-time qPCR. (B) Effect of miR-181a/d on ALDH1 activity in UM6/
he percentage of ALDH1þ cells in each cell type. (C) Endogenous ALDH1 in UM6/
H1 mRNA was determined by real-time qPCR. (D) Decreased ALDH1 activity was
ell population. Percentage of ALDH1þ cells in the CTLi-transfected cells is 100%.
by tumor sphere formation assay. nPo0.05, Student's t test. Representative images
hown on the right side. (F) Effect of ALDH1 knockdown on anchorage independent
Schema depicting HPV16-induced suppression of miR-181a/d, thereby induction of
gative OSCC.
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prisingly, we found that HPV16 led to robust increase in self-
renewal capacity and stemness transcription factors in multiple
HPV-negative OSCC cell lines. Our ﬁndings suggest that HPV16
further promotes malignant progression of HPV-negative OSCC by
increasing self-renewal capacity, a key feature of CSCs.
Furthermore, we demonstrate that HPV16 promotes other CSC
properties, ALDH1 activity and in vitro metastatic potential. HPV16
markedly increases ALDH1þ cell population in multiple HPV-
negative OSCC cell lines. ALDH1 has been found to be a marker for
CSCs in different types of cancer, including OSCC [38,39]. ALDH1þ
cancer cells displayed high self-renewal, migration, and in vivo
tumor-forming capacity compared to ALDH1- cells [38,39]. HPV16
also increases motility and invasion ability of HPV-negative OSCC
cells. Our ﬁndings are consistent with previous observations that
high-risk HPV oncoprotein promoted migration of cervical cancer
cells [38–40]. However, the underlying mechanism by which HPV16
regulates OSCC migration is not understood, warranting further
investigations on the effects of HPV16 on epithelial-to-mesenchy-
mal transition (EMT) and metastasis-related gene expression
[41,42]. Thus, we hypothesize that high-risk HPV infection further
promotes malignant progression of HPV-negative OSCC by enrich-
ing CSC phenotype. Our study further suggests that HPV infection
plays a pivotal role during any stage of cancer development, sup-
porting the potential beneﬁt of HPV vaccination inolder adults.
miRNAs are epigenetic regulators of gene expression and their
deregulation is closely linked to cancer initiation and progression.
Recent studies clearly demonstrated that HPV status affect the
miRNA expression pattern in human SCC [29,31,43]. A number of
cellular miRNAs have been found to be modulated by HPV proteins
and to play important roles in HPV-mediated carcinogenesis [39]. A
recent study reported that miR-181 family members are the most
downregulated miRNAs in HPV16-positive compared to HPV-nega-
tive HNSCC cell line [29]. Consistently, our study showed that HPV16
suppresses miR-181 expression by inhibiting its promoter activity,
indicating for the ﬁrst time that miR-181a and miR-181d are novel
transcription targets of HPV16. Several biomarkers have been iden-
tiﬁed and used for diagnosing HPV-associated cancers, such as
p16INK4a, TOP2A, and surviving [44]. Among these putative bio-
markers, p16INK4a is shown to be a reliable surrogate marker for the
presence of HPV [45]. Although p16INK4a is a known tumor sup-
pressor, its expression is believed to be high in HPV-associated can-
cers due to E7-mediated inactivation of Rb, a negative regulator of
p16INK4a [45]. However, its sensitivity is still questionable because
HPV-negative cancer patients have been shown to express high level
of p16INK4a [46]. Therefore, miR-181a and miR-181d could be used as
potential diagnostic biomarkers, either alone or together, for HPV-
associated oral cancer. It is important to note that high-risk HPV E6
inactivates p53 tumor suppressor, which is known to function as a
transcription factor in regulating miRNAs [47]. However, we are able
to rule out the possible involvement of p53 in the regulation of miR-
181a/d because HPV16 suppresses the expressions of miR-181a/d in
oral keratinocytes containing wild-type p53 (data not shown) and
the OSCC cell lines containing defective p53 gene [30].
Previously, we reported that miR-181a elicits tumor suppressive
activity against OSCC by downregulating K-ras [33]. miR-181d also
acts as tumor suppressor by targeting K-ras [35], indicating that K-ras
is a common target of miR-181a and miR-181d. Activation of K-ras is
implicated in the pathogenesis of oral cancer [48] and CSC in
mammalian cancer [49,50]. These results suggest that miR-181a/d
could be important epigenetic regulators for CSC phenotype via their
target gene(s). In our study, overexpression (restoration) of miR-
181a/d suppressed various CSC properties increased by HPV16,
indicating their CSC-suppressive role in HPV16-positive OSCC. Fur-
thermore, K-ras knockdown resulted in suppression of migration and
anchorage independent growth, but not self-renewal capacity ofHPV16-positive OSCC. Because of the redundant function of miRNA
and multiple targets of miR-181a/d, it is plausible that multiple tar-
gets of miR-181a/d in the HPV16/miR-181 axis may cooperatively
contribute to CSC phenotype. Indeed, we found that ALDH1 is a novel
downstream target of miR-181a/d; it was suppressed by miR-181a/d
in HPV16-positive OSCC. Moreover, knockdown of ALDH1 in HPV16-
positive OSCC suppressed self-renewal and anchorage independent
growth ability, supporting the functional role of ALDH1 in HPV-
mediated oral carcinogenesis. We hypothesize that the HPV16/miR-
181 axis regulates tumor growth and CSC phenotype via multiple
targets of miR-181. Our data also suggest that miR-181a/d may be
novel CSC inhibitors and targeting miR-181a/d may represent a novel
therapeutic approach to suppress CSCs of OSCC.
In conclusion, high-risk HPV directs malignant progression of
OSCC by enhancing stemness properties of OSCC. The HPV-
induced phenotypes are epigenetically mediated by miRNAs. Our
results identiﬁed novel HPV-regulated miRNAs, i.e., miR-181a/d,
whose expression and promoter activity are suppressed by HPV16.
Furthermore, we showed that K-ras and ALDH1, targets of miR-
181a/d, are important players in driving cancer stemness in HPV-
positive OSCC. Thus, our study supports the role of HPV in oral
cancer progression in the context of epigenetic regulation of CSCs.
Moreover, our ﬁnding suggests that HPV may have multiple roles
in various stages of oral carcinogenesis; inducing immortalization
of normal oral epithelial cells and promoting malignant progres-
sion of existing OSCC through enriching cancer stemness via the
miR-181/miR181 targets axis. Future studies should investigate the
correlation between HPV status and miR-181a/d expression, and
the biological outcome of low miR-181a/d expression in vivo.Funding
This work was supported in part by the Grant UCLA School of
Dentistry faculty seed Grant (44190169749SHIN to K.H.S.), the
Grant (R01DE18295 to M.K.K.), the Grant (R01DE023348 to R.H.K.)
from NIDCR/NIH and the Grant from UCLA Chancellor’s Ofﬁce (to
N.H.P.).Disclosure
All authors state that they have no conﬂicts of interest.References
[1] J.N. Al-Swiahb, C.H. Chen, H.C. Chuang, F.M. Fang, H.T. Tasi, C.Y. Chien, Clinical,
pathological and molecular determinants in squamous cell carcinoma of the
oral cavity, Futur Oncol. 6 (2010) 837–850.
[2] C.H. Lee, J.M. Lee, D.C. Wu, H.K. Hsu, E.L. Kao, H.L. Huang, T.N. Wang,
M.C. Huang, M.T. Wu, Independent and combined effects of alcohol intake,
tobacco smoking and betel quid chewing on the risk of esophageal cancer in
Taiwan, Int. J. Cancer 113 (2005) 475–482.
[3] M. Perez-Sayans, J.M. Somoza-Martin, F. Barros-Angueira, M.D. Reboiras-
Lopez, J.M. Gandara Rey, A. Garcia-Garcia, Genetic and molecular alterations
associated with oral squamous cell cancer (review), Oncol. Rep. 22 (2009)
1277–1282.
[4] C.H. Shiboski, B.L. Schmidt, R.C.K. Jordan, Tongue and tonsil carcinoma –
increasing trends in the US population ages 20-44 years, Cancer 103 (2005)
1843–1849.
[5] A.K. Chaturvedi, E.A. Engels, R.M. Pfeiffer, B.Y. Hernandez, W.H. Xiao, E. Kim,
B. Jiang, M.T. Goodman, M. Sibug-Saber, W. Cozen, L.H. Liu, C.F. Lynch,
N. Wentzensen, R.C. Jordan, S. Altekruse, W.F. Anderson, P.S. Rosenberg,
M.L. Gillison, Human papillomavirus and rising oropharyngeal cancer inci-
dence in the United States, J. Clin. Oncol. 29 (2011) 4294–4301.
[6] E.M. Iype, M. Pandey, A. Mathew, G. Thomas, P. Sebastian, M.K. Nair, Squamous
cell carcinoma of the tongue among young Indian adults, Neoplasia 3 (2001)
273–277.
[7] N. Sherin, T. Simi, P. Shameena, S. Sudha, Changing trends in oral cancer,
Indian J. Cancer 45 (2008) 93–96.
S. Hee Lee et al. / Papillomavirus Research 1 (2015) 116–125 125[8] E.M. Smith, J.M. Ritchie, K.F. Summersgill, H.T. Hoffman, D.H. Wang,
T.H. Haugen, L.P. Turek, Human papillomavirus in oral exfoliated cells and risk
of head and neck cancer, J. Natl. Cancer Inst. 96 (2004) 449–455.
[9] B.G. Hansson, K. Rosenquist, A. Antonsson, J. Wennerberg, E.B. Schildt,
A. Bladstrom, G. Andersson, Strong association between infection with human
papillomavirus and oral and oropharyngeal squamous cell carcinoma: a
population-based case-control study in southern Sweden, Acta Oto-Laryngol.
125 (2005) 1337–1344.
[10] J.K. Kellokoski, S.M. Syrjanen, F. Chang, M. Yliskoski, K.J. Syrjanen, Southern
blot hybridization and PCR in detection of oral human papillomavirus (HPV)
infections in women with genital HPV Infections, J. Oral. Pathol. Med. 21
(1992) 459–464.
[11] S. Syrjanen, Viral-infections in oral-mucosa, Scand. J. Dent. Res. 100 (1992)
17–31.
[12] B. Beck, C. Blanpain, Unravelling cancer stem cell potential, Nat. Rev. Cancer 13
(2013) 727–738.
[13] S.H. Chiou, C.C. Yu, C.Y. Huang, S.C. Lin, C.J. Liu, T.H. Tsai, S.H. Chou, C.S. Chien,
H.H. Ku, J.F. Lo, Positive correlations of Oct-4 and Nanog in oral cancer stem-
like cells and high-grade oral squamous cell carcinoma, Clin. Cancer Res. 14
(2008) 4085–4095.
[14] C. Ginestier, M.H. Hur, E. Charafe-Jauffret, F. Monville, J. Dutcher, M. Brown,
J. Jacquemier, P. Viens, C.G. Kleer, S.L. Liu, A. Schott, D. Hayes, D. Birnbaum, M.
S. Wicha, G. Dontu, ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome, Cell Stem Cell 1
(2007) 555–567.
[15] S.L. Liu, G. Dontu, I.D. Mantle, S. Patel, N.S. Ahn, K.W. Jackson, P. Suri, M.
S. Wicha, Hedgehog signaling and Bmi-1 regulate self-renewal of normal and
malignant human mammary stem cells, Cancer Res. 66 (2006) 6063–6071.
[16] R.H. Giles, J.H. van Es, H. Clevers, Caught up in a Wnt storm: Wnt signaling in
cancer, Biochem. Biophys. Acta-Rev. Cancer 2003 (1653) 1–24.
[17] M. Evangelista, H. Tian, F.J. de Sauvage, The hedgehog signaling pathway in
cancer, Clin. Cancer Res. 12 (2006) 5924–5928.
[18] K.G. Leong, A. Karsan, Recent insights into the role of Notch signaling in
tumorigenesis, Blood 107 (2006) 2223–2233.
[19] C. Liu, K. Kelnar, B.G. Liu, X. Chen, T. Calhoun-Davis, H.W. Li, L. Patrawala,
H. Yan, C. Jeter, S. Honorio, J.F. Wiggins, A.G. Bader, R. Fagin, D. Brown, D.A.
G. Tang, The microRNA miR-34a inhibits prostate cancer stem cells and
metastasis by directly repressing CD44, Nat. Med. 17 (2011) 211-U105.
[20] S.J. Song, L. Poliseno, M.S. Song, U. Ala, K. Webster, C. Ng, G. Beringer, N.
J. Brikbak, X. Yuan, L.C. Cantley, A.L. Richardson, P.P. Pandolﬁ, MicroRNA-
antagonism regulates breast cancer stemness and metastasis via TET-family-
dependent chromatin remodeling, Cell 154 (2013) 311–324.
[21] R.W. Carthew, E.J. Sontheimer, Origins and mechanisms of miRNAs and siR-
NAs, Cell 136 (2009) 642–655.
[22] H. Xia, K.M. Hui, MicroRNAs involved in regulating epithelial–mesenchymal
transition and cancer stem cells as molecular targets for cancer therapeutics,
Cancer Gene Ther. 19 (2012) 723–730.
[23] G. Ke, L. Liang, J.M. Yang, X. Huang, D. Han, S. Huang, Y. Zhao, R. Zha, X. He,
X. Wu, MiR-181a confers resistance of cervical cancer to radiation therapy
through targeting the pro-apoptotic PRKCD gene, Oncogene 32 (2013)
3019–3027.
[24] C.C. Yu, Y.W. Chen, G.Y. Chiou, L.L. Tsai, P.I. Huang, C.Y. Chang, L.M. Tseng,
S.H. Chiou, S.H. Yen, M.Y. Chou, P.Y. Chu, W.L. Lo, MicroRNA let-7a represses
chemoresistance and tumourigenicity in head and neck cancer via stem-like
properties ablation, Oral Oncol. 47 (2011) 202–210.
[25] Y. Shi, C. Liu, X. Liu, D.G. Tang, J. Wang, The microRNA miR-34a inhibits non-
small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells,
PloS One 9 (2014) e90022.
[26] Y. Shimono, M. Zabala, R.W. Cho, N. Lobo, P. Dalerba, D. Qian, M. Diehn, H. Liu,
S.P. Panula, E. Chiao, F.M. Dirbas, G. Somlo, R.A. Pera, K. Lao, M.F. Clarke,
Downregulation of miRNA-200c links breast cancer stem cells with normal
stem cells, Cell 138 (2009) 592–603.
[27] U. Wellner, J. Schubert, U.C. Burk, O. Schmalhofer, F. Zhu, A. Sonntag,
B. Waldvogel, C. Vannier, D. Darling, A. zur Hausen, V.G. Brunton, J. Morton,
O. Sansom, J. Schuler, M.P. Stemmler, C. Herzberger, U. Hopt, T. Keck,
S. Brabletz, T. Brabletz, The EMT-activator ZEB1 promotes tumorigenicity by
repressing stemness-inhibiting microRNAs, Nat. Cell Biol. 11 (2009)
1487–1495.
[28] I. Martinez, A.S. Gardiner, K.F. Board, F.A. Monzon, R.P. Edwards, S.A. Khan,
Human papillomavirus type 16 reduces the expression of microRNA-218 in
cervical carcinoma cells, Oncogene 27 (2008) 2575–2582.
[29] C.B. Lajer, E. Garns, L. Friis-Hansen, B. Norrild, M.H. Therkildsen, M. Glud,
M. Rossing, H. Lajer, D. Svane, L. Skotte, L. Specht, C. Buchwald, F.C. Nielsen,The role of miRNAs in human papilloma virus (HPV)-associated cancers:
bridging between HPV-related head and neck cancer and cervical cancer,
Br. J. Cancer 106 (2012) 1526–1534.
[30] C.J. Lin, J.R. Grandis, T.E. Carey, S.M. Gollin, T.L. Whiteside, W.M. Koch, R.
L. Ferris, S.Y. Lai, Head and neck squamous cell carcinoma cell lines: estab-
lished models and rationale for selection, Head Neck-J. Sci. Spec. Head Neck 29
(2007) 163–188.
[31] N.H. Park, B.M. Min, S.L. Li, M.Z. Huang, H.M. Cherick, J. Doniger, Immortali-
zation of normal human oral keratinocytes with type 16 human papilloma-
virus, Carcinogenesis 12 (1991) 1627–1631.
[32] S.H. Lee, H.S. Hong, Z.X. Liu, R.H. Kim, M.K. Kang, N.H. Park, K.H. Shin,
TNFalpha enhances cancer stem cell-like phenotype via Notch-Hes1 activation
in oral squamous cell carcinoma cells, Biochem. Biophys. Res. Commun. 424
(2012) 58–64.
[33] K.H. Shin, S.D. Bae, H.S. Hong, R.H. Kim, M.K. Kang, N.H. Park, miR-181a shows
tumor suppressive effect against oral squamous cell carcinoma cells by
downregulating K-ras, Biochem. Biophys. Res. Commun. 404 (2011) 896–902.
[34] M. Zhang, B. Kumar, L. Piao, X. Xie, A. Schmitt, N. Arradaza, M. Cippola, M. Old,
A. Agrawal, E. Ozer, D.E. Schuller, T.N. Teknos, Q. Pan, Elevated intrinsic cancer
stem cell population in human papillomavirus-associated head and neck
squamous cell carcinoma, Cancer 120 (2014) 992–1001.
[35] X.F. Wang, Z.M. Shi, X.R. Wang, L. Cao, Y.Y. Wang, J.X. Zhang, Y. Yin, H. Luo,
C.S. Kang, N. Liu, T. Jiang, Y.P. You, MiR-181d acts as a tumor suppressor in
glioma by targeting K-ras and Bcl-2, J. Cancer Res. Clin. 138 (2012) 573–584.
[36] K.H. Shin, B.M. Min, H.M. Cherrick, N.H. Park, , Combined effects of human
papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the trans-
formation of normal human oral keratinocytes, Mol. Carcinog. 9 (1994) 76–86.
[37] N. Reddout, T. Christensen, A. Bunnell, D. Jensen, D. Johnson, S. O'Malley,
K. Kingsley, High risk HPV types 18 and 16 are potent modulators of oral
squamous cell carcinoma phenotypes in vitro, Infect. Agents Cancer 2 (2007)
21.
[38] S. Wang, T.Y. Pang, M. Gao, H.X. Kang, W.B. Ding, X.W. Sun, Y. Zhao, W. Zhu,
X.D. Tang, Y.H. Yao, X.R. Hu, HPV E6 induces eIF4E transcription to promote the
proliferation and migration of cervical cancer, FEBS Lett. 587 (2013) 690–697.
[39] S.J. Liao, D.R. Deng, W.N. Zhang, X.J. Hu, W. Wang, H. Wang, Y.P. Lu, S.X. Wang,
L. Meng, D. Ma, Human papillomavirus 16/18 E5 promotes cervical cancer cell
proliferation, migration and invasion in vitro and accelerates tumor growth
in vivo, Oncol. Rep. 29 (2013) 95–102.
[40] C.L.A. Yeung, T.Y. Tsang, P.L. Yau, T.T. Kwok, Human papillomavirus type 16 E6
induces cervical cancer cell migration through the p53/microRNA-23b/uroki-
nase-type plasminogen activator pathway, Oncogene 30 (2011) 2401–2410.
[41] D. Ranieri, F. Belleudi, A. Magenta, M.R. Torrisi, , HPV16 E5 expression induces
switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition, Int.
J. Cancer 137 (2015) 61–72.
[42] Y.S. Jung, I. Kato, H.R.C. Kim, A novel function of HPV16-E6/E7 in epithelial–
mesenchymal transition, Biochem. Biophys. Res. Commun. 435 (2013)
339–344.
[43] A.I. Wald, E.E. Hoskins, S.I. Wells, R.L. Ferris, S.A. Khan, Alteration of microRNA
proﬁles in squamous cell carcinoma of the head and neck cell lines by human
papillomavirus, Head Neck 33 (2011) 504–512.
[44] C.M. Martin, L. Kehoe, C.O. Spillane, J.J. O'Leary, Gene discovery in cervical
cancer: towards diagnostic and therapeutic biomarkers, Mol. Diagn. Ther. 11
(2007) 277–290.
[45] C.H. Chung, M.L. Gillison, Human papillomavirus in head and neck cancer: its
role in pathogenesis and clinical implications, Clin. Cancer Res. 15 (2009)
6758–6762.
[46] N.J. Mulvany, D.G. Allen, S.M. Wilson, Diagnostic utility of p16INK4a: a reap-
praisal of its use in cervical biopsies, Pathology 40 (2008) 335–344.
[47] H. Hermeking, MicroRNAs in the p53 network: micromanagement of tumour
suppression, Nat. Rev. Cancer 12 (2012) 613–626.
[48] C. Caulin, T. Nguyen, M.A. Longley, Z.J. Zhou, X.J. Wang, D.R. Roop, Inducible
activation of oncogenic K-ras results in tumor formation in the oral cavity,
Cancer Res. 64 (2004) 5054–5058.
[49] T. Motohara, S. Masuko, T. Ishimoto, T. Yae, N. Onishi, T. Muraguchi, A. Hirao,
Y. Matsuzaki, H. Tashiro, H. Katabuchi, H. Saya, O. Nagano, Transient depletion
of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-
like cells into tumor-initiating cells, Carcinogenesis 32 (2011) 1597–1606.
[50] Z.W. Wang, S. Ali, S. Banerjee, B. Bao, Y.W. Li, A.S. Azmi, M. Korc, F.H. Sarkar,
Activated K-Ras and INK4a/Arf deﬁciency promote aggressiveness of pan-
creatic cancer by induction of EMT consistent with cancer stem cell pheno-
type, J. Cell Physiol. 228 (2013) 556–562.
